Stefan Gruenwald

Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.

McKesson Medical-Surgical Top Holdings, Inc. markets and distributes medical products and services. It operates through five segments: Physician, Laboratory, Dispensing, Home Care and Hospice Services. The Physician segment business provides products and services to primary care and front line specialists, including those affiliated with or owned by health systems. The Laboratory segment provides laboratory equipment, supplies and services to individual physician office laboratories, clinics and small hospital laboratories. The Dispensing segment engages in helping front line caregivers improve patient outcomes and practice strength through the detection, diagnosis and treatment of illness and disease. The Home Care and Hospice segment provides products and services to caregivers to allow them to efficiently deliver care to patients in the home or hospice settings. The company was founded by Patrick C. Kelly in 1983 and is headquartered in Jacksonville, FL.

Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington.

Biolog, Inc. enages in the manufacture of diagnostic substances. It offers microbial identification, phenotype microarrays for microbial and mammalian cells, mitochondria function assays, educational porta, microbiome, microbial community analysis, and microbial detection. The company was founded by Barry R. Bochner and Donald W. Barnby in 1984 and is headquartered in Hayward, CA.

Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.

Xoft, Inc. develops Electronic Brachytherapy systems for radiation therapy applications. Its products include the Axxent Controller, which utilizes a miniaturized high dose rate (HDR) X-ray source to apply radiation directly to the cancerous tumor bed; Axxent HDR X-ray Source, a low energy radiation treatment without the use of radioactive isotopes; Axxent Applicators, which provides a channel for the Axxent X-ray Source to deliver high dose rate, low energy radiation directly to the targeted area; and Axxent Accessories, an accessory product line designed to support and aid a physician during a procedure or treatment of cancer radiation. The company was founded by Michael Forman in 1998 and is headquartered in San Jose, CA.

Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA.

Simpson Thacher & Bartlett LLP provides legal services. Its areas of practices include corporate, litigation, banking and credit, capital markets, mergers and acquisitions, real estate, private funds, intellectual property, restructuring and bankruptcy, and tax. The firm serves the energy, financial services, healthcare, insurance and reinsurance, technology, retail, defense, education and transportation industries. The company operates through its offices located in Beijing, Hong Kong, Houston, London, Los Angeles, New York, Palo Alto, São Paulo, Seoul, Tokyo and Washington, DC. Simpson Thacher & Bartlett was founded in 1884 and is headquartered in New York, NY.

Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA.

Healthcare Distribution Alliance operates membership organizations. The firm distributes healthcare and pharmaceutical products. It delivers to pharmacies, hospitals, nursing homes, and health clinics. It provides members to share industry practices, represents member concerns before Congress and regulatory agencies, and publishes newsletters. The company is headquartered in Arlington, VA.

Myriad RBM, Inc. provides protein biomarker products and services. Its biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species. The company was founded in 1998 and is headquartered in Salt Lake City, UT.

Arrayjet Ltd. develops and produces microarray printing technologies for researchers, drug development groups, and diagnostic companies. Its products include Sprint, Marathon and Super Marathon, Ultra Marathon I and II Microarrayers. The company was founded by Howard John Manning, Peter Ghazal and Douglas Roy in 2000 and is headquartered in Roslin, the United Kingdom.

Fluidic Analytics Ltd. develops proprietary technology to characterize proteins. The company was founded by Tuomas Knowles in 2013 and is headquartered in Cambridge, the United Kingdom.

Nuclera Nucleics Ltd. is a British company that specializes in making biology accessible through desktop enzymatic protein and gene synthesis. The company was founded in 2013 by four PhD students at the University of Cambridge who were frustrated by the inaccessibility of biology. Nuclera has since grown to fifty-seven employees across two continents and is headquartered in Cambridge, UK. The company's vision is to make biology accessible to everyone through desktop bioprinting, which empowers researchers and scientists to take control of biology through streamlined access to a next-day supply of proteins and genes. Nuclera's desktop bioprinter is enabled by three exciting technologies protected by 45+ patents: enzymatic protein synthesis, enzymatic gene synthesis, and digital microfluidics. The combination of these technologies in a deployable desktop bioprinting platform creates an unprecedented one-stop-shop ecosystem that enables Nuclera to provide consistent biological workflows, products, and information to its customers. Michael Chen has been the CEO since 2013.

Part of UnitedHealth Group, Inc., Morris County Surgical Center LLC is a healthcare company based in Parsippany, NJ. The company is focused on providing high-quality surgical services to patients, physician specialists, and their staff. The company uses advanced technology and equipment to provide optimal clinical care in a warm, personalized setting. The Morris Country Surgical Center is committed to providing quality healthcare, as evidenced by their accreditation by the Accreditation Association for Ambulatory Health Care (AAAHC). To expedite the check-in process, patients are required to submit their registration form prior to their procedure date. A health history nurse will also call patients prior to their surgery to collect information about their health to expedite the admission process.

Attovia Therapeutics manufactures a pipeline for bio therapeutics to immune-mediated diseases including cancer. The company is based in Sacramento, CA. Attovia Therapeutics was founded by Tao Fu and Tao Fu has been the CEO since incorporation.